Averin Capital
Venture capitalActively deployingNew York · Seed–Growth · 9 people tracked
Also known as AVERIN CAPITAL LLC
Investment thesis
Averin Capital invests where technology and health converge, supporting visionary teams driving significant shifts in human health—from early disease detection and improved treatment delivery to personalized care and major medical breakthroughs. Positioned as an operator-led firm, its team includes MDs, PhDs, experienced company founders, healthcare executives, and professionals from finance and consulting, having founded or launched over 30 companies. The firm combines scientific rigor, operational expertise, and strategic insight to help entrepreneurs scale. It emphasizes being a respectful partner of choice that knows when to engage and when to step back, aiming to empower exceptional teams to reach their fullest potential.
Source: firm website, verified Aug 25, 2026.
Team · 9 people
from the firm's website
What they invest in
from 6 of 12 portfolio companiesDigital Health ×6Healthtech ×5Medical Devices ×4AI & Machine Learning ×1Biotech ×1Consumer ×1Hardware ×1Robotics ×1
HQs:United States×4
Investments · 12 tracked
founders shown can be your intro pathBy year:2026 · 12015 · 12 dated
Freenome develops early-stage cancer detection technology using blood tests to identify cancer in its earliest, most treatable phases.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon
Riley Ennis(Co-Founder and Chief Product Officer)Charles Roberts(Director)inGabriel Otte(Director)in
BoardStuart Lawson(Director)
Co-investorsRA CapitalAME Cloud VenturesAndreessen HorowitzArtis VenturesAsset Management CompanyBain Capital Life Sciences+8 more
Commons Clinic is an orthopedic care provider offering treatment for spine, joint, and sports medicine conditions, along with preventive health services such as full-body MRI and biomarker labs.
Digital HealthHealthtechWellness & FitnessAustin, US
Brad Hively(Director)Nick Aubin(Founder)inNicholas Scott Aubin(Executive Officer, Director)Paulo Marques Da Costa(Executive Officer, Director)Prithviraj Singha Roy(Director)
BoardJohn Loser(Director)in
Board seatTristan Hunt· per SEC Form D · $10.1M raise · filed Jul 2026
Co-investorsCourtside VenturesFloating PointNorth South VenturesSteelSky VenturesTime BioVenturesRA Capital
Biolinq develops the Shine sensor, a needle-free glucose monitor that measures glucose along with physical activity and sleep in a single wearable device.
Digital HealthHardwareMedical Devices
Jared Tangney(Founder)inRich Yangin
Co-investorsAble PartnersAlpha Wave GlobalAphelion CapitalBOLD LongevityHikma VenturesM Ventures+2 more
A product designed to be better for patients, easier and more cost-effective for practitioners while addressing market needs.
New York, US
Nicholas Greenfield(Executive Officer, Director)Jacob Goldfield(Director)Don Kingsborough(Director)Zachary Frankel(Executive Officer, Director)
BoardJohn Elton(Director)
Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.
ConsumerDigital HealthHealthtechMedical Devices
Nick Greenfield(Co-founder & CEO)in
Co-investorsA-Rod CorpBessemer Venture PartnersBeyond CapitalF-Prime CapitalKube VCDigitalis Ventures+2 more
Combines biosensors and GLP-1 receptor agonists to revolutionize diabetes care through real-time monitoring, personalized insights, and better blood sugar control with weight management.
A clinical-stage artificial intelligence company using Large Medicine Models to optimize drug development, especially in late-stage clinical trials.
Co-investorsMana Ventures
A pioneering liquid biopsy company pursuing FDA approvals for cancer diagnostics with leading sensitivity and specificity.
Mendaera builds robotic technology, including its Focalist System for robotic-guided access and procedures such as transplant biopsy, to help healthcare providers perform reproducible clinical procedures.
Digital HealthHealthtechMedical DevicesRoboticsSan Mateo, US
Josh DeFonzo(Founder)inJason Wilson(Founder)
Co-investorsThreshold VenturesFounders FundLux CapitalFemHealth VenturesSonder CapitalMana Ventures+1 more
Pine Park Health operates a team-based primary care model that provides medical care, preventive screening, and health coordination services for patients.
Digital HealthHealthtechSan Francisco, US
Payam Parvinchiha(Chief Medical Officer)
Co-investorsGradient VenturesY CombinatorBoxGroupUnshackled Ventures
Co-investorsGunung CapitalImpact EngineThe Engine Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioFreenomeNASDAQ: FRNM
Portfolio news
latest coverage across their companies
Commons Clinic · intelligence360.news · Jul 17, 2026
Pine Park Health · healthcareitnews.com · Feb 6, 2026
Hologen AI · aimsmall.substack.com · Feb 2, 2026
Biolinq · fiercebiotech.com · Sep 29, 2025
Frequently asked questions
- How many investments has Averin Capital made?
- Averin Capital has 11 tracked investments.
- What stage does Averin Capital invest at?
- Averin Capital invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Averin Capital focus on?
- Averin Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Robotics.
- Where is Averin Capital located?
- Averin Capital is headquartered in New York, US.
- Who does Averin Capital co-invest with?
- Averin Capital most often shares deals with Andreessen Horowitz, Bessemer Venture Partners, CRV (Charles River Ventures), among 33 tracked co-investors.
From the blog
visit blog ↗Averin Capital has written on structural barriers to AI adoption in biotech: talent loss driven by job design rather than compensation, liability gaps blocking clinical AI deployment, and state-level regulatory changes creating alternative pathways for experimental medicine commercialization." AI summary
Media · Podcasts & interviews
featuring the teamAverin Capital Managing Partner David Berry on what it was like to work with Bob Langer.
BiotechTV · David Berry
Transforming Healthcare Through Technology: Insights from Averin Capital’s David Berry
Mission Matters Money with Adam Torres · David Berry
Images
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It backs transformative entrepreneurs building industry-defining technologies with global scale potential.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.